{
  "document_id": "IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_I/Development/IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement.pdf",
  "text_length": 30479,
  "chunk_count": 41,
  "vector_store_path": "output/vector_stores/IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement",
  "summary": "representatives of the Parties. No approval, consent or waiver will be enforceable unless signed by the granting Party. Failure to insist on\nstrict performance or to exercise a right when entitled does not prevent a Party from doing so later for that breach, or a future breach.\n9.16 Incorporation. This Agreement, Appendix A and SOW\u2019s added as Appendix A-x (where x is the sequential number of the respectively\nadded SOW\u2019s) are the complete and exclusive agreement between the Parties regarding the subject matter hereof and supersedes any\nprior oral or written communications or understandings between the parties related to the subject matter hereof.\n9.17 Independent Judgment. The Parties acknowledge that: (a) they had read this Agreement\u037e (b) they understand the terms and conditions of\nthis Agreement\u037e (c) they have had the opportunity to seek legal counsel and advice\u037e (d) are of equal bargaining power\u037e and (e) they have\nrelied on their own judgment in entering into this Agreement.\n\nproduction of Product(s) and work to be performed under this Agreement. Each Product will be set forth in a separate Statement of Work\nin the form set forth in Appendix A, which will be signed by representatives of each Party with signing authority. Each phase of the\nproject(s) will be subject to the terms and conditions set forth in this Agreement unless otherwise provided for or in a Statement of Work\n(\u201cSOW\u201d), including but not limited to project purpose, project phases, and a project budget.\nMaster Joint Development Agreement iBio CC-Pharming Page 1 of 12\nSource: IBIO, INC., 8-K, 3/13/2020\n\nexpenses and court costs from the non-prevailing Party.\n9.0 General Provisions\n9.1 Independent Contractor. Each Party is an independent contractor. Neither Party is, nor will claim to be, a legal representative, partner,\nfranchisee, agent or employee of the other. Neither Party will assume or create obligations for the other. Each Party is responsible for the\ndirection and compensation of its employees.\n9.2 Trademarks. Except as otherwise provided herein, this Agreement does not confer any rights to use in advertising, publicity or other\nmarketing activities any name, trade name, trademark, or other designation of either Party hereto, including any contraction, abbreviation,\nor simulation of any of the foregoing, without prior written agreement, and each Party agrees not to use or refer to this Agreement or its\nterms in any such activities without the express written approval of the other Party.\nMaster Joint Development Agreement iBio CC-Pharming Page 8 of 12\n\n6.0 Term and Termination\n6.1 The term of this Agreement (\u201cTerm\u201d) will begin on the date this Agreement is signed by the last signatory (\u201cEffective Date\u201d) and remain in\neffect for  [***] \u037e provided, however, that the terms of this Agreement shall remain applicable to any SOW that was executed by the Parties\nprior to the expiration or termination of this Agreement but whose period of performance extends beyond the expiration or termination of\nthis Agreement.\n6.2 The term of any SOW will be as provided in the Statement of Work.\n6.3 If either Party to this Agreement fails to perform or violates any material obligation of this Agreement, then, upon thirty (30) days written\nnotice to the breaching Party specifying such failure or violation, the non-breaching Party may terminate this Agreement without liability,\nunless: (a) the failure or violation specified in the default notice has been cured within the thirty (30) day notice period\u037e or (b) the failure or",
  "parties": "expenses and court costs from the non-prevailing Party.\n9.0 General Provisions\n9.1 Independent Contractor. Each Party is an independent contractor. Neither Party is, nor will claim to be, a legal representative, partner,\nfranchisee, agent or employee of the other. Neither Party will assume or create obligations for the other. Each Party is responsible for the\ndirection and compensation of its employees.\n9.2 Trademarks. Except as otherwise provided herein, this Agreement does not confer any rights to use in advertising, publicity or other\nmarketing activities any name, trade name, trademark, or other designation of either Party hereto, including any contraction, abbreviation,\nor simulation of any of the foregoing, without prior written agreement, and each Party agrees not to use or refer to this Agreement or its\nterms in any such activities without the express written approval of the other Party.\nMaster Joint Development Agreement iBio CC-Pharming Page 8 of 12\n\nrepresentatives of the Parties. No approval, consent or waiver will be enforceable unless signed by the granting Party. Failure to insist on\nstrict performance or to exercise a right when entitled does not prevent a Party from doing so later for that breach, or a future breach.\n9.16 Incorporation. This Agreement, Appendix A and SOW\u2019s added as Appendix A-x (where x is the sequential number of the respectively\nadded SOW\u2019s) are the complete and exclusive agreement between the Parties regarding the subject matter hereof and supersedes any\nprior oral or written communications or understandings between the parties related to the subject matter hereof.\n9.17 Independent Judgment. The Parties acknowledge that: (a) they had read this Agreement\u037e (b) they understand the terms and conditions of\nthis Agreement\u037e (c) they have had the opportunity to seek legal counsel and advice\u037e (d) are of equal bargaining power\u037e and (e) they have\nrelied on their own judgment in entering into this Agreement.\n\nwith conference calls or video conferences upon request by a Party.\n2.4.4 The Parties shall be responsible for their own respective costs incurred relating to their participation in oversight meetings.\nMaster Joint Development Agreement iBio CC-Pharming Page 3 of 12\nSource: IBIO, INC., 8-K, 3/13/2020\n\n9.10 Power to Enter Agreement. Each Party represents that it has, or will have, in place appropriate agreements with its employees or others\nwhose services the Party may require, sufficient to enable such Party to comply with all the provisions of this Agreement.\n9.11 Independent Parties. Each Party may have similar agreements with others, and may design, develop, manufacture, acquire or market\ncompetitive products and services, and conduct its business in whatever way it chooses. Each Party will independently establish prices\nand terms for its products and services.\n9.12 Severability. If any provision of this Agreement is held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the\nremaining provisions shall in no way be affected or impaired thereby so long as the intent of the Parties can be preserved.\n9.13 Governing Law. This Agreement is governed by the laws of the State of Texas, without regard to the conflict of laws provisions thereof.",
  "key_terms": "6.0 Term and Termination\n6.1 The term of this Agreement (\u201cTerm\u201d) will begin on the date this Agreement is signed by the last signatory (\u201cEffective Date\u201d) and remain in\neffect for  [***] \u037e provided, however, that the terms of this Agreement shall remain applicable to any SOW that was executed by the Parties\nprior to the expiration or termination of this Agreement but whose period of performance extends beyond the expiration or termination of\nthis Agreement.\n6.2 The term of any SOW will be as provided in the Statement of Work.\n6.3 If either Party to this Agreement fails to perform or violates any material obligation of this Agreement, then, upon thirty (30) days written\nnotice to the breaching Party specifying such failure or violation, the non-breaching Party may terminate this Agreement without liability,\nunless: (a) the failure or violation specified in the default notice has been cured within the thirty (30) day notice period\u037e or (b) the failure or\n\nrepresentatives of the Parties. No approval, consent or waiver will be enforceable unless signed by the granting Party. Failure to insist on\nstrict performance or to exercise a right when entitled does not prevent a Party from doing so later for that breach, or a future breach.\n9.16 Incorporation. This Agreement, Appendix A and SOW\u2019s added as Appendix A-x (where x is the sequential number of the respectively\nadded SOW\u2019s) are the complete and exclusive agreement between the Parties regarding the subject matter hereof and supersedes any\nprior oral or written communications or understandings between the parties related to the subject matter hereof.\n9.17 Independent Judgment. The Parties acknowledge that: (a) they had read this Agreement\u037e (b) they understand the terms and conditions of\nthis Agreement\u037e (c) they have had the opportunity to seek legal counsel and advice\u037e (d) are of equal bargaining power\u037e and (e) they have\nrelied on their own judgment in entering into this Agreement.\n\nexpenses and court costs from the non-prevailing Party.\n9.0 General Provisions\n9.1 Independent Contractor. Each Party is an independent contractor. Neither Party is, nor will claim to be, a legal representative, partner,\nfranchisee, agent or employee of the other. Neither Party will assume or create obligations for the other. Each Party is responsible for the\ndirection and compensation of its employees.\n9.2 Trademarks. Except as otherwise provided herein, this Agreement does not confer any rights to use in advertising, publicity or other\nmarketing activities any name, trade name, trademark, or other designation of either Party hereto, including any contraction, abbreviation,\nor simulation of any of the foregoing, without prior written agreement, and each Party agrees not to use or refer to this Agreement or its\nterms in any such activities without the express written approval of the other Party.\nMaster Joint Development Agreement iBio CC-Pharming Page 8 of 12\n\n7.7 The parties agree that limitations on disclosure of Confidential information under section 7.3 shall last 5 years from signing date.\n8.0 Representations, Warranties, Disclaimers and Limitation of Liability\n8.1 ANY PROTOTYPES, MATERIALS, COMPONENT PARTS, DESIGNS, SPECIFICATIONS, KNOW-HOW, PROCEDURES, PROCESSES,\nDATA, INFORMATION, INVENTIONS AND WORK PERFORMED UNDER THIS AGREEMENT BY EITHER PARTY, ARE PROVIDED\n\u201cAS IS\u201d, WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. EACH PARTY SPECIFICALLY DISCLAIMS THE IMPLIED\nWARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, AND ANY WARRANTY OF\nNONINFRINGEMENT OF PATENTS, COPYRIGHTS, OR ANY OTHER INTELLECTUAL PROPERTY RIGHT.\n8.2 EACH PARTY ALSO SPECIFICALLY DISCLAIMS ANY GUARANTEE THAT IT WILL BE ABLE TO SUCCESSFULLY ACHIEVE THE\nDESIRED RESULTS REGARDING THE WORK UNDER ANY STATEMENT OF WORK, OR THAT ANY PROTOTYPE(S) WHICH MAY BE\nDEVELOPED PURSUANT TO THIS AGREEMENT WILL MEET ANY DEVELOPMENT OBJECTIVES, OR ANY REQUIREMENTS OF"
}